Table 2

Differential expression data for genes encoding key IRFs in HIV-1–treated MDDCs

SymbolAccession no.6 Hours24 Hours48 Hours
IRF-1 NM_002198 2.7 ± 0.9 4.6 ± 1.0 7.4 ± 1.2 
IRF-2 NM_002199 No change 1.7 ± 0.2 2.7 ± 0.7 
IRF-3 NM_001571 No change No change No change 
IRF-4 NM_002460 No change 3.9 ± 1.0 4.4 ± 0.9 
IRF-7 NM_004031 3.9 ± 0.25 5.0 ± 0.7 4.9 ± 1.6 
IRF-8 NM_002163 8.9 ± 3.7 2.7 ± 0.7 1.2 ± 0.1 
IRF-9 NM_006084 No change 3.8 ± 0.6 1.8 ± 0.7 
SymbolAccession no.6 Hours24 Hours48 Hours
IRF-1 NM_002198 2.7 ± 0.9 4.6 ± 1.0 7.4 ± 1.2 
IRF-2 NM_002199 No change 1.7 ± 0.2 2.7 ± 0.7 
IRF-3 NM_001571 No change No change No change 
IRF-4 NM_002460 No change 3.9 ± 1.0 4.4 ± 0.9 
IRF-7 NM_004031 3.9 ± 0.25 5.0 ± 0.7 4.9 ± 1.6 
IRF-8 NM_002163 8.9 ± 3.7 2.7 ± 0.7 1.2 ± 0.1 
IRF-9 NM_006084 No change 3.8 ± 0.6 1.8 ± 0.7 

Day 6 MDDCs were mock-treated or treated with HIV-1BaL (MOI, 10), and IRF gene expression was determined by qPCR. Data are mean fold change ± SE in the expression of IRF genes in HIV-1–treated cells at 6, 24, and 48 hours after treatment from 4 independent experiments.

Close Modal

or Create an Account

Close Modal
Close Modal